Description

Carfizome 60mg Injection (Carfilzomib) Uses, Side Effects, Dosage & Price in Pakistan

Carfizome 60mg Injection (Carfilzomib) is an oncology medicine intended for use under specialist medical supervision. Carfilzomib belongs to a class of medicines known as proteasome inhibitors and is used in the treatment of certain adults with multiple myeloma, a cancer affecting plasma cells in the bone marrow. The exact treatment plan depends on the patient’s condition, previous therapies, and the oncologist’s assessment.

For patients and caregivers in Pakistan, understanding the uses, dosage precautions, possible side effects, and availability of Carfizome 60mg Injection can help support informed discussions with a healthcare professional. Impo Medic provides medicine-related information to help customers learn about oncology products and explore their availability in Pakistan.

What Is Carfizome 60mg Injection (Carfilzomib)?

Carfizome 60mg Injection contains carfilzomib, a targeted anticancer medicine that interferes with the proteasome system inside cancer cells. Proteasomes help cells break down unwanted or damaged proteins. By inhibiting this system, carfilzomib can cause harmful proteins to accumulate in myeloma cells, disrupting their normal function and potentially leading to cell death.

Carfilzomib is administered intravenously by trained healthcare professionals. Although 60mg is the strength stated in the product name, the amount prescribed for an individual patient is determined according to the treatment regimen and body surface area, not simply the vial strength.

The medicine may be prescribed alone or in combination with other anticancer medicines, depending on the patient’s treatment history and the approved regimen applicable to the product.

Uses of Carfizome 60mg Injection (Carfilzomib)

The main established medical use of carfilzomib is the treatment of certain adults with relapsed or refractory multiple myeloma. Relapsed disease means the cancer has returned after treatment, while refractory disease means it has not responded adequately or has stopped responding to therapy.

1. Treatment of Multiple Myeloma

Multiple myeloma develops when abnormal plasma cells multiply in the bone marrow. These cells can interfere with normal blood cell production and may contribute to bone damage, kidney problems, and other complications.

Carfilzomib helps target these abnormal cells by blocking proteasome activity. The objective is to control the disease, reduce cancer activity, and support the overall treatment plan.

2. Treatment After Previous Cancer Therapies

Carfizome may be considered for eligible patients whose multiple myeloma has returned or progressed following earlier treatment. The decision depends on the medicines already used, the response to previous therapy, the patient’s overall health, and the oncologist’s assessment.

3. Combination Cancer Treatment

Carfilzomib may be prescribed with other medicines, such as dexamethasone, lenalidomide, daratumumab, or isatuximab, depending on the relevant treatment regimen and patient eligibility.

These medicines work through different mechanisms and may be combined to improve disease control. Not every combination is suitable for every patient.

Important: The approved indications for a specific Carfizome-branded product should be confirmed using its authorized prescribing information. Carfilzomib’s established indications should not be interpreted as evidence that every patient with multiple myeloma is eligible for this treatment.

How Does Carfizome 60mg Injection Work?

Carfilzomib inhibits proteasomes, which are protein-processing structures inside cells. Cancer cells, including multiple myeloma cells, rely on protein regulation to survive and multiply.

When proteasome activity is blocked, unwanted proteins accumulate inside susceptible cells. This creates cellular stress and can trigger cell death. The effect may help slow the growth and survival of malignant plasma cells.

Carfilzomib is not a general pain-relief medicine or a routine treatment for every type of cancer. Its use requires a specific diagnosis, appropriate treatment selection, and monitoring by an oncology specialist.

Dosage and Administration of Carfizome 60mg Injection

The dosage of Carfizome 60mg Injection must be determined by a qualified oncologist. Carfilzomib regimens vary according to the medicines used alongside it, the treatment schedule, body surface area, previous response, and tolerability.

The prescribed dose may differ from the total amount contained in a vial. Therefore, patients should never assume that one complete vial represents a single treatment dose.

Important administration considerations include:

• Route: Intravenous administration by trained healthcare professionals.
• Treatment schedule: Depends on the selected oncology regimen and may involve repeated treatment cycles.
• Dose adjustments: May be necessary if significant side effects occur or if the patient has certain liver or other medical problems.
• Hydration: The healthcare team may recommend fluids before and after treatment to reduce particular treatment-related risks.
• Monitoring: Blood pressure, blood counts, kidney function, liver function, and other relevant parameters may need regular assessment.

Do not self-administer Carfizome or change the prescribed schedule. Preparation, reconstitution, storage, and infusion must follow the product’s official instructions.

Side Effects of Carfizome 60mg Injection

Carfilzomib can cause side effects ranging from mild symptoms to serious complications. The likelihood and severity depend on the individual patient, dosage regimen, and other medicines used during treatment.

Common Side Effects

Possible side effects include:

• Fatigue or unusual weakness
• Nausea
• Diarrhea
• Fever
• Headache
• Cough
• Shortness of breath
• Anemia or reduced red blood cell levels
• Low platelet counts
• Increased blood pressure
• Swelling of the hands, feet, or ankles
• Insomnia or difficulty sleeping

Not every patient experiences these effects. Report persistent, worsening, or troublesome symptoms to the treating healthcare team.

Serious Side Effects and Warning Signs

Carfilzomib can also cause serious adverse reactions, including:

Heart problems: The medicine may cause heart failure, reduced heart function, or other cardiovascular complications. Seek urgent assessment for chest pain, sudden swelling, or new or worsening breathlessness.

Kidney problems: Kidney function may deteriorate during treatment. Changes in urine output, significant swelling, or unusual weakness should be reported promptly.

Lung complications: Severe breathing difficulties or other serious pulmonary reactions may occur. Sudden or severe shortness of breath requires urgent medical attention.

High blood pressure: Blood pressure can rise significantly in some patients. Regular monitoring is important, especially in those with pre-existing hypertension.

Low blood cell counts: Reduced platelets can increase bleeding risk, while anemia may cause fatigue or dizziness. Fever during cancer treatment may indicate a serious infection and should be assessed urgently.

Infusion-related reactions: Fever, chills, dizziness, rash, or breathing difficulties can occur around the time of administration.

Tumor lysis syndrome: Rapid destruction of cancer cells can produce dangerous changes in blood chemistry and may affect kidney function.

Blood clots or bleeding: Carfilzomib treatment may be associated with thrombotic or bleeding complications, particularly in patients with additional risk factors.

Contact the treating oncology team immediately if concerning symptoms develop. Severe chest pain, major breathing difficulty, fainting, or signs of a stroke require emergency care.

Precautions Before Using Carfizome 60mg Injection

Before treatment begins, patients should provide their doctor with a complete medical history and an updated list of medicines and supplements.

Heart and Blood Pressure Conditions

Tell the doctor about heart failure, coronary artery disease, irregular heartbeat, previous heart attacks, or uncontrolled high blood pressure. These conditions may affect treatment suitability and monitoring requirements.

Kidney and Liver Problems

Patients with kidney or liver impairment may need closer observation or adjustments to their treatment plan. The healthcare team will decide which tests and precautions are necessary.

Pregnancy and Breastfeeding

Carfilzomib may cause harm to an unborn baby. Patients who could become pregnant should discuss pregnancy prevention and the required duration of contraception with their oncologist. Men receiving treatment should also discuss contraception where relevant.

Breastfeeding should be avoided during treatment according to the applicable prescribing guidance. Ask the treating specialist when breastfeeding may safely resume.

Other Medicines

Inform the doctor about all prescription medicines, non-prescription products, vitamins, and herbal supplements. Other cancer medicines and drugs affecting blood pressure, clotting, or kidney function may influence treatment decisions.

Monitoring During Treatment

The healthcare team may arrange blood tests, kidney and liver assessments, blood pressure checks, and cardiac evaluations when appropriate. Keeping scheduled appointments is important even if the patient feels well.

Who Should Avoid or Use Carfizome With Extra Caution?

Carfizome should only be used when an oncology specialist determines that its potential benefits justify its risks.

Extra caution is important for patients with:

• Significant heart disease or poorly controlled blood pressure
• Existing kidney impairment
• Liver dysfunction
• Previous serious reactions to carfilzomib
• Active infections or significant abnormalities in blood counts
• A history of blood clots or bleeding problems
• Pregnancy or plans to become pregnant

These conditions do not all automatically prohibit treatment. The oncologist must assess the patient’s individual circumstances and the applicable product information before prescribing the medicine.

Storage and Handling of Carfizome 60mg Injection

Carfizome 60mg Injection should be stored and handled according to the instructions provided with the specific product. The correct storage temperature, protection from light, reconstitution procedure, and permitted period of use after preparation must be confirmed from its official packaging and prescribing information.

The medicine should be handled by trained healthcare professionals. Do not use a vial if its packaging is damaged, the seal appears compromised, or its authenticity and storage history cannot be established. Keep oncology medicines away from children and do not attempt to prepare or inject them at home.

Carfizome 60mg Injection Price in Pakistan

The price of Carfizome 60mg Injection in Pakistan may vary according to the supplier, availability, product source, and applicable pharmacy or distribution charges. A confirmed current price should be obtained from a reliable supplier before placing an order.

Impo Medic aims to help customers explore medicine availability in Pakistan and obtain product-related information. Contact the website or its support team to ask about the current availability and applicable price of Carfizome 60mg Injection.

A quoted price should be confirmed before purchase, particularly for specialist oncology medicines that may have variable stock availability.

Availability of Carfizome 60mg Injection in Pakistan

Availability of Carfizome 60mg Injection may vary between cities, pharmacies, and authorized medicine suppliers in Pakistan. Specialist cancer medicines can require additional verification because product authenticity, storage conditions, and supply continuity are important.

Customers looking for Carfizome 60mg Injection in Pakistan can contact Impo Medic to enquire about current stock, product details, and purchasing arrangements.

Before buying, confirm the exact brand name, 60mg strength, packaging, expiry date, batch details, and appropriate storage conditions. The medicine should be obtained from a reputable supplier and used only under specialist supervision.

Why Choose Impo Medic?

Impo Medic provides an online platform for customers seeking information about medicines and their availability in Pakistan. For a specialist medicine such as Carfizome 60mg Injection, clear product information and appropriate purchasing guidance can help patients and caregivers ask the right questions before ordering.

When enquiring through Impo Medic, customers should confirm:

• Whether Carfizome 60mg Injection is currently available
• The exact product strength and packaging
• The current price and applicable delivery arrangements
• Product authenticity and expiry details
• Any documentation or prescription required for purchase

Availability should always be confirmed directly. A product listing alone does not guarantee current stock, and patients should not delay essential cancer treatment while searching for a particular brand.

How to Buy Carfizome 60mg Injection in Pakistan

If you need Carfizome 60mg Injection (Carfilzomib), visit Impo Medic and enquire about the product’s current availability and purchasing requirements.

Before completing an order, make sure that the product name and strength match the prescription. Confirm the supplier’s credentials, packaging, batch number, expiry date, storage requirements, and delivery arrangements. Follow any prescription or documentation requirements applicable to this specialist medicine.

Carfizome should only be administered by qualified healthcare professionals. Patients and caregivers should coordinate with the treating oncologist to ensure that the correct product is obtained and that treatment can proceed according to the prescribed schedule.

Frequently Asked Questions About Carfizome 60mg Injection (Carfilzomib)

1. What is Carfizome 60mg Injection used for?

Carfizome contains carfilzomib, a proteasome inhibitor used in eligible adults with certain forms of relapsed or refractory multiple myeloma. Its use depends on the patient’s treatment history and the prescribed oncology regimen.

2. What is the active ingredient in Carfizome 60mg Injection?

The active ingredient stated in the product name is carfilzomib. Confirm the ingredient and strength on the actual product packaging before use.

3. How is Carfizome 60mg Injection administered?

It is administered into a vein by trained healthcare professionals. The dose, infusion schedule, and number of treatment cycles are determined by the oncologist.

4. What are the common side effects of Carfizome?

Possible side effects include fatigue, nausea, diarrhea, fever, headache, anemia, low platelet counts, high blood pressure, swelling, and shortness of breath. Serious symptoms require prompt medical assessment.

5. Can Carfizome 60mg Injection cure multiple myeloma?

Carfilzomib is used to control multiple myeloma in eligible patients. Treatment response varies, and it should not be described as a guaranteed cure.

6. Can Carfizome be used without a prescription?

No. Carfizome is a specialist anticancer medicine and must be prescribed and administered under appropriate medical supervision.

7. What is the price of Carfizome 60mg Injection in Pakistan?

The current price may vary with supply and the seller. Contact Impo Medic to confirm the latest price and availability rather than relying on an unverified online figure.

8. Where can I check Carfizome 60mg Injection availability in Pakistan?

You can contact Impo Medic to enquire about current availability, product details, and purchasing arrangements. Confirm stock and delivery before relying on a product listing.

9. What precautions are important during Carfizome treatment?

Patients should attend scheduled monitoring appointments and report symptoms such as chest pain, severe breathlessness, unusual bleeding, fever, or reduced urine output. The oncology team should know about all existing medical conditions and medicines.